Hampshire and Isle of Wight Integrated Care System (HIOW ICS) identified hypertension (HTN) and atrial fibrillation (AF) as clinical priorities. The 2022/2023 Quality Outcomes Framework (QOF) data shows that HIOW have improved their screening and registration for HTN, decreasing their projected unidentified HTN population from 125,065 to 103,340. This remains, however, well below the national average.
Building from the wave 1 Innovation for Healthcare Inequalities Programme (InHIP) and the evaluation reported by Health Innovation Wessex in 2023/2024, the 2024/2025 InHIP programme maintained a focus on providing HTN and AF clinical checks in primary care networks (PCNs) serving socio-economically deprived communities.
The InHIP wave 2 programme objective was to increase access to CVD services through outreach and engagement of local at-risk populations and to target those who are more socio-economically deprived and traditionally under-served. In line with the NICE guidelines, the programme sought to uncover unidentified health issues in asymptomatic patients by increasing awareness of HTN and delivering HTN check-ups in patients aged 45 and over who have not had their blood pressure checked in the last five years.
The activities were clinic or community led and were built on pre-existing outreach groups or existing clinics to co-deliver and collaborate between community, health, and social care. The more socio-economically deprived areas included in this programme were Isle of Wight (IOW) (One Wight Health GP practices and public health), Bitterne PCN in Southampton, and Island City PCN in Portsmouth. All three areas used data-driven approaches to identify their target cohort, dependent on their population needs. In Dorset Health Innovation Wessex has worked with Shore Medical to support their introduction of BP specific clinics and utilisation of OMRON in line with an ICB wide initiative and incentive scheme.
Read more about our primary care approach to CVD prevention
